Showing results (631-640 of 675) with videos related to
Sort By:
Pageof 68
Clinical and Experimental Immunology|October 17, 2007
Activation of granulocytes by direct interaction with dendritic cellsM Tsuda, M Inaba, Y Sakaguchi, et al.Cancer Letters|July 6, 2000
Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breastY Ando, H Iwase, S Ichihara, et al.The American Journal of Physiology|March 10, 1999
AVP inhibits LPS- and IL-1beta-stimulated NO and cGMP via V1 receptor in cultured rat mesangial cellsT Umino, E Kusano, S Muto, et al.Journal of Hypertension|September 17, 1999
The effect of erythropoietin on interleukin-1beta mediated increase in nitric oxide synthesis in vascular smooth muscle cellsT Akimoto, E Kusano, S Muto, et al.Kidney International|February 13, 1999
Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritisY Isaka, Y Akagi, Y Ando, et al.British Journal of Cancer|August 7, 2008
Midkine as a prognostic biomarker in oral squamous cell carcinomaK Ota, H Fujimori, M Ueda, et al.Clinical Pharmacology and Therapeutics|January 3, 2008
Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humansY Yamasaki, I Ieiri, H Kusuhara, et al.Oncology Reports|October 14, 1998
No susceptibility of colon tissue implanted into the glandular stomach of rats to N-nitroso-N-methylurea carcinogenesisY Ando, T Uesaka, S Kido, et al.Internal Medicine (Tokyo, Japan)|March 1, 1996
Distribution of dystrophin and dystrophin-associated protein 43DAG (beta-dystroglycan) in the central nervous system of normal controls and patients with Duchenne muscular dystrophyM Uchino, A Hara, Y Mizuno, et al.Neurology|October 12, 2005
Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosisM Nakamura, T Yamashita, M Ueda, et al.Pageof 68